Theodoros Kelesidis - Concepedia

Author

Theodoros Kelesidis

University of California, Los Angeles ORCID

Also Known As

Kelesidis Theodoros, Kelesidis, Theodoros, T Kelesidis, T. KELESIDIS, T. Kelesidis, T.H Kelesidis, Theo Kelesidis, Theodore Kelesidis, Theodoros Kelesidis, Theodoros, Kelesidis

229

Publications

8.8K

Citations

H-Index

157

Concepts

All Affiliations

University of California, Los Angeles Harvard University University of Southern California Beth Israel Deaconess Medical Center University of Wisconsin–Madison

About

Theodoros Kelesidis is an author at University of California, Los Angeles specializing in medicine, health sciences, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	33	1.5K
2	Health Sciences	12	14	565
3	Public Health	6	6	192
4	Engineering	1	1	24
5	Allergy	1	1	56

Theodoros Kelesidis

Publications

4.2K

Citations

H-Index

Page 1

	Year	Citations
Efficacy and safety of the probiotic <i>Saccharomyces boulardii</i> for the prevention and therapy of gastrointestinal disorders Theodoros Kelesidis, Charalabos Pothoulakis Therapeutic Advances in Gastroenterology Saccharomyces BoulardiiProbioticDysbiosisGastrointestinal DisordersGastrointestinal Pharmacology	2011	344
Plasma Adiponectin Concentrations and Risk of Incident Breast Cancer Shelley S. Tworoger, A. Heather Eliassen, Theodoros Kelesidis, The Journal of Clinical Endocrinology & Metabolism	2007	274
Cord Blood Leptin and Adiponectin as Predictors of Adiposity in Children at 3 Years of Age: A Prospective Cohort Study Christos S. Mantzoros, Sheryl L. Rifas‐Shiman, Catherine J. Williams, PEDIATRICS	2009	243
Total and High-Molecular-Weight Adiponectin in Breast Cancer:<i>In Vitro</i>and<i>in Vivo</i>Studies Antje Körner, Kalliopi Pazaitou‐Panayiotou, Theodoros Kelesidis, The Journal of Clinical Endocrinology & Metabolism	2006	216
Biomarkers of Microbial Translocation and Macrophage Activation: Association With Progression of Subclinical Atherosclerosis in HIV-1 Infection Theodoros Kelesidis, Michelle A. Kendall, Otto O. Yang, The Journal of Infectious Diseases	2012	211
Body Composition Changes After Initiation of Raltegravir or Protease Inhibitors: ACTG A5260s Grace A. McComsey, Carlee Moser, Judith S. Currier, Clinical Infectious Diseases	2016	162
Daptomycin Nonsusceptible Enterococci: An Emerging Challenge for Clinicians Theodoros Kelesidis, Romney M. Humphries, Daniel Z. Uslan, Clinical Infectious Diseases	2010	148
Regulation of adiponectin and its receptors in response to development of diet-induced obesity in mice John W. Bullen, Susann Blüher, Theodoros Kelesidis, American Journal of Physiology-Endocrinology and Metabolism AdipokinesInsulin SignalingGastrointestinal Peptide HormoneObesityMetabolic Syndrome	2006	145
Assessment of empirical antibiotic therapy optimisation in six hospitals: an observational cohort study Nikolay Braykov, Daniel J. Morgan, Marin L. Schweizer, The Lancet Infectious Diseases AntibioticsDrug ResistanceAntibiotic AdjuvantHealthcare-associated InfectionPatient Safety	2014	127
Total and High–Molecular Weight Adiponectin in Relation to Metabolic Variables at Baseline and in Response to an Exercise Treatment Program Matthias Blüher, Aoife Brennan, Theodoros Kelesidis, Diabetes Care	2007	121

Page 1